Trophogen Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
Trophogen General Information
Description
Operator of a biotechnology platform designed to focus on the development of growth factors for therapeutic applications. The company's platform offers high-affinity glycoprotein hormones, veterinary reproduction agents, and related growth factor analogs for enhanced reproductive outcomes, enabling fertility specialists, cancer researchers, and medical professionals to treat ovarian, breast, prostate, testicular, and thyroid cancers as well as human and animal infertility.
Contact Information
Website
www.trophogen.comCorporate Office
- 9430 Key West Avenue
- Suite 155
- Rockville, MD 20850
- United States
Corporate Office
- 9430 Key West Avenue
- Suite 155
- Rockville, MD 20850
- United States
Trophogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Secondary Transaction - Private | 01-Dec-2020 | Completed | Clinical Trials - Phase 2 | |||
| 15. Grant | 01-Aug-2018 | Completed | Clinical Trials - Phase 2 | |||
| 14. Grant | 18-Sep-2017 | Completed | Clinical Trials - Phase 2 | |||
| 13. Grant | 22-Aug-2017 | Completed | Clinical Trials - Phase 2 | |||
| 12. Later Stage VC (Series B) | 14-Feb-2017 | Cancelled | Clinical Trials - Phase 2 | |||
| 11. Grant | 08-Jul-2015 | Completed | Clinical Trials - Phase 2 | |||
| 10. Grant | 21-Apr-2014 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 11-Sep-2012 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 12-Sep-2011 | $1.94M | $3.5M | Completed | Clinical Trials - Phase 2 | |
| 7. Grant | 29-Oct-2010 | $478K | $3.5M | Completed | Clinical Trials - Phase 2 |
Trophogen Patents
Trophogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024233992-A2 | Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs | Inactive | 11-May-2023 | ||
| WO-2024233992-A3 | Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs | Inactive | 11-May-2023 | ||
| AU-2014346859-A1 | Glycoprotein hormone long-acting superagonists | Active | 05-Nov-2013 | ||
| AU-2014346859-B2 | Glycoprotein hormone long-acting superagonists | Inactive | 05-Nov-2013 | ||
| CA-2929561-A1 | Glycoprotein hormone long-acting superagonists | Pending | 05-Nov-2013 | C07K14/59 |
Trophogen Signals
Trophogen FAQs
-
When was Trophogen founded?
Trophogen was founded in 2001.
-
Where is Trophogen headquartered?
Trophogen is headquartered in Rockville, MD.
-
What is the size of Trophogen?
Trophogen has 10 total employees.
-
What industry is Trophogen in?
Trophogen’s primary industry is Biotechnology.
-
Is Trophogen a private or public company?
Trophogen is a Private company.
-
What is Trophogen’s current revenue?
The current revenue for Trophogen is .
-
How much funding has Trophogen raised over time?
Trophogen has raised $3.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process